Investment
Features
FeesSafety
Academy
More
Pluang+

Ripple's ex-CTO regrets early XRP and Ethereum sales driven by risk aversion, missing later gains.

Market News
21 Jul 2026
Crypto news
View Source
Neutral
pluang ai news

David Schwartz, former CTO of Ripple, expressed regret over selling early XRP and Ethereum holdings, decisions driven by a personal risk-averse strategy rather than loss of confidence in crypto. He followed a family agreement to sell at new all-time highs, reducing exposure to volatile assets despite missing out on substantial later gains. Schwartz's approach reflects a preference for managing financial risk over chasing maximum returns, and he continues to hold Ripple equity while reducing direct cryptocurrency holdings. His comments highlight the trade-off between risk management and potential upside in crypto investing.

More News

FDH Aero and LATECOERE sign global hardware supply deal supporting aerospace manufacturing in six countries

FDH Aero and LATECOERE sign global hardware supply deal supporting aerospace manufacturing in six countries

FDH Aero and LATECOERE have entered a global supply agreement, making FDH Hardware a key supplier for LATECOERE's manufacturing sites in Brazil, Bulgaria, France, the Czech Republic, Tunisia, and Morocco. This partnership aligns FDH Aero's hardware p...

Company Fundamentals
Bullish
1 hour ago
YieldMax ETFs declare weekly distributions for multiple option income ETFs starting July 23, 2026.

YieldMax ETFs declare weekly distributions for multiple option income ETFs starting July 23, 2026.

YieldMax ETFs announced weekly distributions for its Group 1 option income ETFs, with payments scheduled for July 23, 2026. The distributions vary by ETF, with rates ranging from about 26% to over 60% annualized based on recent NAV, reflecting income...

Company Fundamentals
Neutral
2 hours ago
BioNTech to release Q2 2026 results and host investor webcast on August 4, highlighting oncology progress.

BioNTech to release Q2 2026 results and host investor webcast on August 4, highlighting oncology progress.

BioNTech SE will announce its second quarter 2026 financial results on August 4, 2026, followed by a webcast and conference call for investors and the public. The event will cover financial performance and updates on BioNTech's oncology pipeline, whi...

Company Fundamentals
Neutral
2 hours ago
Investec Bank discloses share dealings for Advanced Medical Solutions Group on July 20, 2026.

Investec Bank discloses share dealings for Advanced Medical Solutions Group on July 20, 2026.

Investec Bank plc, acting as advisor and joint broker to Advanced Medical Solutions Group plc, disclosed its share dealings on July 20, 2026. The bank purchased 1,786,258 ordinary shares and sold 1,952,322 ordinary shares at prices around 279 to 280 ...

Market News
Neutral
3 hours ago
Investec Bank discloses share dealings for Gooch & Housego plc on July 20, 2026.

Investec Bank discloses share dealings for Gooch & Housego plc on July 20, 2026.

Investec Bank plc, acting as advisor and broker to Gooch & Housego plc, disclosed its share transactions on July 20, 2026. The bank purchased 2,788 ordinary shares and sold 7,308 ordinary shares at prices between 1215 and 1220 per share. There were n...

Market News
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App